Top 10 sleep disorder stories of 2024
Click Here to Manage Email Alerts
Healio Pulmonology has compiled the top news on sleep disorders posted in 2024.
Readers were most interested in learning more about the link between severe obstructive sleep apnea and premature aging, a nasal spray treatment that lessens sleep apnea severity in select patients with OSA, a CPAP alternative that offers “more flexibility and comfort” to patients, the FDA’s clearance to a mandibular advancement device designed to reduce snoring and the impact daily almond consumption has on sleep quality.
Here are Healio’s top 10 most-read stories on sleep disorders from 2024.
More severe OSA linked to premature aging in adults
A heightened oxygen desaturation index was significantly linked to epigenetic age acceleration determined via two epigenetic clocks, according to a presentation at the American Thoracic Society International Conference. Read more.
Nasal spray treatment lessens sleep apnea severity in select patients
Patients with obstructive sleep apnea who achieved upper airway collapsibility improvement with a drug administered via nasal spray also had lower disease severity after use of the spray, according to study results published in American Journal of Physiology Heart and Circulatory Physiology. Read more.
Q&A: CPAP alternative offers ‘more flexibility and comfort’ to patients with OSA
In an effort to improve patient tolerability of OSA treatment, University of Cincinnati (UC) researchers designed the VortexPAP to be a less intrusive and more comfortable CPAP alternative. Healio spoke with Liran Oren, PhD, research associate professor in the department of otolaryngology at the UC College of Medicine, to learn more. Read more.
FDA grants 510(k) clearance to snoring-reducing device
The FDA has granted 510(k) clearance to Mouth Guard+, a mandibular advancement device designed to reduce snoring, according to a press release from SnoreLessNow. Read more.
Daily almond consumption improves sleep quality
Adults with poor sleep quality had improved Pittsburgh Sleep Quality Index and Epworth Sleepiness Scale scores with 20-week daily almond consumption, according to data presented at the European Respiratory Society International Congress. Also, Lena Bakovic, MS, RDN, CNSC, registered dietitian nutritionist specializing in gut health, chronic disease, weight management, intuitive eating, oncology and general health and wellness at Top Nutrition Coaching, shares her Perspective. Read more.
Q&A: How doctors can encourage good sleep hygiene among patients
Binge-watching a TV show and online shopping are common reasons adults stay up past their bedtimes, according to a survey conducted by the American Academy of Sleep Medicine (AASM). Healio spoke with Alexandre Abreu, MD, AASM spokesperson, sleep physician and associate professor at University of Miami Miller School of Medicine, to learn more. Read more.
Impact of OSA on future cardiovascular events differs by BMI
Among adults with acute coronary syndrome not classified as having obesity, obstructive sleep apnea raised the risk for major cardiovascular and cerebrovascular events, according to results published in CHEST. Read more.
OSA pharmacotherapy reduces disease severity
A combination pharmacotherapy for obstructive sleep apnea led to greater reductions in disease severity compared with placebo, according to results from a proof-of-concept phase 2 trial. Read more.
Q&A: Determining usefulness of inpatient sleep tests for sleep-disordered breathing
Individuals with suspected sleep-disordered breathing must undergo sleep testing to be formally diagnosed and treated. However, the benefits of inpatient vs. outpatient sleep assessments are unclear. Healio spoke with Tetyana Kendzerska, MD, PhD, associate professor in the department of medicine at the University of Ottawa, to learn more about this topic. Read more.
Children treated for OSA less likely to have mental health care visits
Children with obstructive sleep apnea treated with adenotonsillectomy/positive airway pressure faced reduced odds for mental health care visits vs. before treatment, according to results published in Annals of the American Thoracic Society. Also, Shalini Paruthi, MD, AASM spokesperson, shares her Perspective. Read more.